NDC codes

461357 NDC codes with hospital pricing data in the network.

• NDC 71288050110 — NEOSTIGMINE METHYLSULFATE IV SOLN 10 MG/10 ML (1 MG/ML) (74 hospitals, 611–1,340 samples)
• NDC 00054-0010-20 — FLECAINIDE 50 MG ORAL TAB (184 hospitals, 1,213–1,339 samples)
• NDC 00143-9720-24 — LEVOFLOXACIN IN D5W 750 MG/150ML IV SOLN (144 hospitals, 1,078–1,339 samples)
• NDC 00409-5922-01 — AMINOPHYLLINE 25 MG/ML IV SOLN (282 hospitals, 574–1,339 samples)
• NDC 63323082074 — fat emul-soy-mct-oliv-fish oil 20 % Emulsion 250 mL BAG (231 hospitals, 1,078–1,339 samples)
• NDC 00002-4115-01 — OLANZapine 5 mg Tab (28 hospitals, 1,222–1,339 samples)
• NDC 00093-8740-01 — MEXILETINE HCL 200 MG PO CAPS (170 hospitals, 1,293–1,338 samples)
• NDC 00093-8739-01 — MEXILETINE HCL 150 MG PO CAPS (209 hospitals, 1,293–1,338 samples)
• NDC 14789-0220-08 — leveTIRACetam 1000mg in NaCl 0.75% 100mL PREMIX (56 hospitals, 1,014–1,338 samples)
• NDC 10019-0179-44 — MORPHINE 15MG/ML 20ML INJ (4 hospitals, 1,203–1,338 samples)
• NDC 00270141125 — IOPAMIDOL 200 MG IODINE/ML (41 %) INTRATHECAL SOLUTION (108 hospitals, 276–1,338 samples)
• NDC 64679075901 — FUROSEMIDE 10 MG/ML INJECTION SOLUTION (57 hospitals, 474–1,338 samples)
• NDC 73463-0309-08 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INTRAVENOUS SYRINGE WRAPPER (13 hospitals, 1,140–1,338 samples)
• NDC 63323-0495-04 — Lidocaine *PF* Inj 2% 5 mL (89 hospitals, 1,103–1,337 samples)
• NDC 00054-8724-25 — PREDNISONE 5 MG ORAL TAB (221 hospitals, 625–1,336 samples)
• NDC 00270-1317-09 — IOPAMIDOL 250 MG IODINE/ML (51 %) INTRAVENOUS SOLUTION (40 hospitals, 985–1,336 samples)
• NDC 60505614700 — CEFEPIME HCL FOR IV SOLN 2 GM (353 hospitals, 148–1,336 samples)
• NDC 67457034815 — AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION (113 hospitals, 274–1,336 samples)
• NDC 00562780505 — RHO D IMMUNE GLOBULIN IM SOLN PREF SYR 1500 UNIT (300MCG) (97 hospitals, 445–1,336 samples)
• NDC 00781328809 — clindamycin 300 mg/50 mL in 5 % dextrose intravenous piggyback (105 hospitals, 1,102–1,336 samples)
• NDC 00143-9702-01 — Irinotecan Inj 20 mg/mL (IV) (80 hospitals, 1,164–1,335 samples)
• NDC 25021-0230-02 — Irinotecan Inj 20 mg/mL (IV) (76 hospitals, 1,164–1,335 samples)
• NDC 63323-0193-52 — Irinotecan Inj 20 mg/mL (IV) (35 hospitals, 1,164–1,335 samples)
• NDC 00703-4434-81 — INJECTION, IRINOTECAN, 20 MG (8 hospitals, 1,164–1,335 samples)
• NDC 27241-0125-02 — ranolazine 500 mg ER Tab (138 hospitals, 1,226–1,334 samples)
• NDC 00536-1256-28 — BACITRACIN EX OINTMENT TUBE (INPT) (62 hospitals, 1,235–1,334 samples)
• NDC 00409477702 — ciprofloxacin 400 mg/200 mL in 5 % dextrose intravenous piggyback (178 hospitals, 155–1,334 samples)
• NDC 70092112548 — MORPHINE 30 MG/30 ML (1 MG/ML) IN 0.9 % SODIUM CHLORIDE IV PCA SYRINGE (49 hospitals, 443–1,334 samples)
• NDC 72603050125 — HEPARIN (PORCINE) 10,000 UNIT/ML INJECTION SOLUTION (32 hospitals, 209–1,334 samples)
• NDC 59651-0299-60 — TAMOXIFEN TAB (144 hospitals, 1,306–1,333 samples)
• NDC 24201010024 — ACETAMINOPHEN 1000 MG/100 ML IV SOLN (248 hospitals, 1,018–1,333 samples)
• NDC 55150015872 — LIDOCAINE SOLN PF 1% 2 ML (112 hospitals, 1,179–1,332 samples)
• NDC 24200-0258-45 — FENTANYL 25MCG/ML 50MLPCA (1 hospital, 1,287–1,332 samples)
• NDC 00002-8215-17 — INSULIN REG 10U/0.1ML INJ (93 hospitals, 701–1,331 samples)
• NDC 63739064410 — 63739-0644-10 - ALPRAZolam 0.25 mg Tab (44 hospitals, 1,249–1,330 samples)
• NDC 67253090010 — ALPRAZolam 0.25 mg tablet (100 hospitals, 1,249–1,330 samples)
• NDC 00781311390 — PIPERACILLIN SOD-TAZOBACTAM NA FOR INJ 3.375 GM (3-0.375 GM) (165 hospitals, 133–1,330 samples)
• NDC 13533-0692-20 — Albumin Inj 25% 12.5 GM/50 mL (UD) (31 hospitals, 1,105–1,330 samples)
• NDC 55150-0301-10 — INJECTION, PHENYLEPHRINE HYDROCHLORIDE, 20 MICROGRAMS (31 hospitals, 1,114–1,330 samples)
• NDC 66658-0501-01 — Emapalumab-lzsg 10 MG/2ML Soln 2 mL Vial (36 hospitals, 1,312–1,330 samples)
• NDC 72603047425 — FUROSEMIDE 10 MG/ML INJECTION SOLUTION (56 hospitals, 448–1,330 samples)
• NDC 63020-0049-01 — BORTEZOMIB 3.5MG PWD INJ (242 hospitals, 1,176–1,329 samples)
• NDC 23155-0601-42 — MIDazoLAM *PF* Inj 5 mg/mL 1 mL (UD) (52 hospitals, 950–1,328 samples)
• NDC 50419032001 — GADOXETATE 0.25 MMOL/ML (181.43 MG/ML) INTRAVENOUS SOLUTION (103 hospitals, 149–1,328 samples)
• NDC 39822-1000-01 — TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) IV SOLN (113 hospitals, 1,111–1,327 samples)
• NDC 70069-0801-01 — INJECTION, PHENYLEPHRINE HYDROCHLORIDE, 20 MICROGRAMS (36 hospitals, 1,129–1,327 samples)
• NDC 00054-8739-25 — PREDNISONE 1 MG PO TABS (225 hospitals, 696–1,326 samples)
• NDC 67457034810 — ampicillin-sulbactam 1.5 gram solution for injection (159 hospitals, 273–1,326 samples)
• NDC 10702-0006-01 — cycloBENZaprine Tab 5 mg (54 hospitals, 1,155–1,326 samples)
• NDC 409428212 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (46 hospitals, 1,029–1,326 samples)